News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
316,996 Results
Type
Article (17275)
Company Profile (138)
Press Release (299575)
Multimedia
Podcasts (75)
Webinars (13)
Section
Business (101352)
Career Advice (579)
Deals (24202)
Drug Delivery (81)
Drug Development (39709)
Employer Resources (55)
FDA (7207)
Job Trends (7391)
News (175792)
Policy (15573)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (559)
Accelerated approval (15)
Adcomms (9)
Allergies (74)
Alliances (25906)
ALS (60)
Alzheimer's disease (543)
Antibody-drug conjugate (ADC) (129)
Approvals (7422)
Artificial intelligence (236)
Autoimmune disease (60)
Automation (18)
Bankruptcy (181)
Best Places to Work (5311)
BIOSECURE Act (9)
Biosimilars (126)
Biotechnology (64)
Bladder cancer (41)
Brain cancer (36)
Breast cancer (197)
Cancer (1598)
Cardiovascular disease (184)
Career advice (520)
Career pathing (17)
CAR-T (70)
CDC (6)
Cell therapy (204)
Cervical cancer (14)
Clinical research (34545)
Collaboration (854)
Company closure (1)
Compensation (372)
Complete response letters (37)
COVID-19 (935)
CRISPR (47)
C-suite (514)
Cystic fibrosis (60)
Data (2168)
Denatured (18)
Depression (58)
Diabetes (150)
Diagnostics (2053)
Digital health (15)
Diversity (2)
Diversity, equity & inclusion (15)
Drug discovery (131)
Drug pricing (121)
Drug shortages (15)
Duchenne muscular dystrophy (87)
Earnings (40488)
Editorial (25)
Employer branding (5)
Employer resources (52)
Events (42510)
Executive appointments (611)
FDA (8540)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (520)
Gene editing (79)
Generative AI (19)
Gene therapy (210)
GLP-1 (526)
Government (1580)
Grass and pollen (4)
Guidances (232)
Healthcare (5069)
HIV (27)
Huntington's disease (10)
IgA nephropathy (46)
Immunology and inflammation (93)
Immuno-oncology (21)
Indications (65)
Infectious disease (1022)
Inflammatory bowel disease (97)
Inflation Reduction Act (7)
Influenza (30)
Intellectual property (138)
Interviews (74)
IPO (7361)
IRA (35)
Job creations (2296)
Job search strategy (461)
JPM (37)
Kidney cancer (9)
Labor market (35)
Layoffs (265)
Leadership (11)
Legal (3944)
Liver cancer (27)
Longevity (8)
Lung cancer (247)
Lymphoma (141)
Machine learning (18)
Management (19)
Manufacturing (483)
MASH (76)
Medical device (2890)
Medtech (2903)
Mergers & acquisitions (17654)
Metabolic disorders (525)
Multiple sclerosis (59)
NASH (14)
Neurodegenerative disease (110)
Neuropsychiatric disorders (49)
Neuroscience (1036)
Neurotech (1)
NextGen: Class of 2026 (2128)
Non-profit (707)
Now hiring (21)
Obesity (288)
Opinion (163)
Ovarian cancer (41)
Pain (118)
Pancreatic cancer (64)
Parkinson's disease (92)
Partnered (15)
Patents (259)
Patient recruitment (143)
Peanut (14)
People (32957)
Pharmaceutical (67)
Pharmacy benefit managers (19)
Phase 1 (9093)
Phase 2 (14651)
Phase 3 (13141)
Pipeline (2463)
Policy (143)
Postmarket research (1445)
Preclinical (3683)
Press Release (25)
Prostate cancer (98)
Psychedelics (19)
Radiopharmaceuticals (158)
Rare diseases (392)
Real estate (3038)
Recruiting (22)
Regulatory (12009)
Reports (17)
Research institute (679)
Resumes & cover letters (76)
Rett syndrome (8)
RNA editing (8)
RSV (24)
Schizophrenia (91)
Series A (99)
Series B (59)
Service/supplier (4)
Sickle cell disease (48)
Special edition (12)
Spinal muscular atrophy (90)
Sponsored (13)
Startups (1930)
State (2)
Stomach cancer (6)
Supply chain (58)
Tariffs (70)
The Weekly (55)
Vaccines (298)
Venture capital (41)
Weight loss (181)
Women's health (33)
Worklife (4)
Date
Today (18)
Last 7 days (211)
Last 30 days (906)
Last 365 days (12248)
2026 (1572)
2025 (12683)
2024 (14804)
2023 (16879)
2022 (22970)
2021 (23965)
2020 (22583)
2019 (18078)
2018 (14284)
2017 (16082)
2016 (15013)
2015 (17639)
2014 (13918)
2013 (11714)
2012 (12699)
2011 (13278)
2010 (12101)
Location
Africa (363)
Alabama (22)
Alaska (1)
Arizona (93)
Arkansas (3)
Asia (23389)
Australia (3051)
California (3910)
Canada (1726)
China (625)
Colorado (170)
Connecticut (177)
Delaware (145)
Europe (47119)
Florida (723)
Georgia (101)
Hawaii (1)
Idaho (15)
Illinois (392)
India (46)
Indiana (291)
Iowa (3)
Japan (288)
Kansas (81)
Kentucky (21)
Louisiana (12)
Maine (7)
Maryland (505)
Massachusetts (3084)
Michigan (71)
Minnesota (190)
Mississippi (1)
Missouri (40)
Montana (9)
Nebraska (8)
Nevada (21)
New Hampshire (18)
New Jersey (1603)
New Mexico (8)
New York (1117)
North Carolina (751)
North Dakota (3)
Northern California (1773)
Ohio (104)
Oklahoma (5)
Oregon (22)
Pennsylvania (880)
Puerto Rico (13)
Rhode Island (22)
South America (593)
South Carolina (17)
Southern California (1679)
Tennessee (112)
Texas (546)
United States (15416)
Utah (82)
Vermont (1)
Virginia (173)
Washington D.C. (45)
Washington State (309)
West Virginia (3)
Wisconsin (51)
Wyoming (1)
316,996 Results for "processa pharmaceuticals heatwurx acquired promet".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
January 13, 2026
·
2 min read
Press Releases
Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
December 18, 2025
·
5 min read
Press Releases
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
January 5, 2026
·
4 min read
Press Releases
Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025
November 6, 2025
·
3 min read
Press Releases
Processa Pharmaceuticals Provides Portfolio and Business Update
July 2, 2025
·
4 min read
Press Releases
Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering
June 18, 2025
·
4 min read
Press Releases
Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
June 16, 2025
·
2 min read
Press Releases
Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting
May 30, 2025
·
3 min read
Press Releases
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
March 19, 2025
·
1 min read
Press Releases
Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate
June 17, 2025
·
4 min read
1 of 31,700
Next
